(Bloomberg) — A little known biotech company, ABVC BioPharma Inc., soared in U.S. premarket trading amid increasing chatter on trading social network StockTwits.Most Read from BloombergInto the Metaverse: Where Crypto, Gaming and Capitalism CollideCan a New Mayor Fix Seattle’s Downtown?The Terrifying Rise of Haunted TourismThe Best New Restaurants in Washington, Chosen by Top ChefsIn Minneapolis Election, the Future of Policing Is at StakeThe Fremont, California-based firm’s shares jumped as mu
